Abiliity Pharmaceuticals SL (fomerly AB Therapeutics), founded in November 2009 and headquartered in Spain, is a drug discovery and development company focussed on the development of therapeutics targeting cell membranes for cancer and other indications.In September 2012, the company planned for US facilities in Boston during 2013.In December 2018, the company closed a round of financing worth more than EUR 1,230,000 (US $1,398,300) through the crowdfunding platform Capital Cell . With the figure, the company exceeded the EUR 1 million (US $1.13) with which they had opened the campaign last September, and happened to be the largest round of Capital Cell.In September 2012, the company raised EUR 1 million (US $ 1.3 million) in a second financing round.By November 2010, the company had initiated a series A financing round; in April 2015, the series A financing round of EUR 10 million (US $10.98 million) was ongoing.In October 2020 AbilityPharma receives of t